| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/09/2007 | US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 01/09/2007 | CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 01/09/2007 | CA2309790C Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/09/2007 | CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 01/09/2007 | CA2269097C Synthesis and purification of hepatitis c virus-like particles |
| 01/09/2007 | CA2203885C Treating red blood cell solutions with anti-viral agents |
| 01/09/2007 | CA2162732C Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/09/2007 | CA2159988C Novel deoxygalactonojirimycin derivatives |
| 01/04/2007 | WO2007002912A2 Anti-proliferative compounds, compositions, and methods of use thereof |
| 01/04/2007 | WO2007002441A1 Methods of use for non-atp competitive tyrosine kinase inhibitors to treat pathogenic infection |
| 01/04/2007 | WO2007002173A1 Hiv-1 protease inhibitors, and methods of making and using them |
| 01/04/2007 | WO2007002172A2 Hiv-1 protease inhibitors |
| 01/04/2007 | WO2007002051A1 Carboline derivatives and their use as inhibitors of flaviviridae infections |
| 01/04/2007 | WO2007001058A1 Herpesvirus-derived therapeutic agent for pain |
| 01/04/2007 | WO2007000779A2 Pharmaceutical sustained release compositions and processes thereof |
| 01/04/2007 | WO2007000644A1 Homomorpholine oxazolidinones as antibacterial agents |
| 01/04/2007 | WO2007000473A1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 01/04/2007 | WO2007000472A1 Self-sterilizing products |
| 01/04/2007 | WO2007000436A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000435A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000434A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000432A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | WO2007000343A2 Process for manufacturing vaccines |
| 01/04/2007 | WO2007000342A2 Immunogenic composition |
| 01/04/2007 | WO2007000314A2 Immunogenic composition |
| 01/04/2007 | WO2007000043A2 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 01/04/2007 | WO2006117660A3 Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins |
| 01/04/2007 | US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
| 01/04/2007 | US20070004768 Hydroxamates of isoquinolines, imidazopyridines and pyrrolopyridines, used to treat AIDS and AIDS-related complex |
| 01/04/2007 | US20070004756 Pharmaceutical compositions |
| 01/04/2007 | US20070004735 Method for inhibiting the replication of herpes viruses |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/04/2007 | US20070004669 Mono-, di- or trifluoromethyl derivatives, e.g., 6-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)purine, 2'-C-(fluoromethyl)-5-methylcytidine and 2-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)-3,9-dihydropurin-6-thione; used to treat a hepatitis C virus infection |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | US20070003560 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 01/04/2007 | US20070003542 Methods for treating diseases or conditions with peptide constructs |
| 01/04/2007 | DE102005027293A1 Use of horseradish to combat bacterial infection in herbivorous domestic animal, preferably horse, by administering specified amount of the horseradish daily for several days |
| 01/04/2007 | CA2667449A1 Hiv-1 protease inhibitors, and methods of making and using them |
| 01/04/2007 | CA2667445A1 Hiv-1 protease inhibitors |
| 01/04/2007 | CA2613662A1 Antimicrobial materials |
| 01/04/2007 | CA2613647A1 Self-sterilizing products comprising a polymer bound to a phthalocyanine derivative |
| 01/04/2007 | CA2613407A1 Pharmaceutical sustained release compositions and processes thereof |
| 01/04/2007 | CA2612969A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | CA2612963A1 Immunogenic compositions comprising nisseria menningitidis capsular saccharide |
| 01/04/2007 | CA2612901A1 Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
| 01/04/2007 | CA2612623A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612619A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612614A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612300A1 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 01/04/2007 | CA2611964A1 Process for manufacturing vaccines |
| 01/04/2007 | CA2610978A1 Homomorpholine oxazolidinones as antibacterial agents |
| 01/04/2007 | CA2583121A1 Immunogenic compositions of staphylococcus epidermidis polypeptide antigens |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738764A1 Glycopeptides of the V3 loop of gp120 and derivatives; preparation and applications as HIV-1 vaccines. |
| 01/03/2007 | EP1737883A2 Synthetic peptides containing the motif "ywwlxp" as anthrax toxin antidotes |
| 01/03/2007 | EP1737862A1 Imidazopyridine compound |
| 01/03/2007 | EP1737859A1 Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo¬4.3.0|nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 01/03/2007 | EP1737836A1 Antiviral agents |
| 01/03/2007 | EP1737821A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737488A1 Treatment of fungal infections |
| 01/03/2007 | EP1737459A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
| 01/03/2007 | EP1737425A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease |
| 01/03/2007 | EP1701726A4 Antimicrobial photodynamic therapy compound and method of use |
| 01/03/2007 | EP1596851B1 The use of sodium 2-mercaptoethanesulfonate as antiviral agent |
| 01/03/2007 | EP1476467B9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1444522B1 Screening for antiviral agents affecting signal peptidase |
| 01/03/2007 | EP1439843A4 Tetracycline derivatives and methods of use thereof |
| 01/03/2007 | EP1430075B1 Antibacterial macrocycles |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1385876B1 Gonococcal proteins and nucleic acids |
| 01/03/2007 | EP1334124B1 Diastereomeric peptides and pharmaceutical compositions comprising them |
| 01/03/2007 | EP1326636B1 Vaccine composition |
| 01/03/2007 | EP1322292B1 Microparticle compositions and methods for the manufacture thereof |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | EP1278515B1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 01/03/2007 | EP1267920B1 Compositions comprising cold-adapted equine influenza viruses for the treatment of existing viral infections of the respiratory system. |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1210116B1 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP0787139B1 Synthetic peptides and vaccines comprising same |
| 01/03/2007 | EP0771213B1 Haemophilus influenzae adherence and penetration proteins |
| 01/03/2007 | EP0726952B1 Receptor on the surface of activated t-cells:acts-4 |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890252A New class of gamma delta T cells activators and use thereof |
| 01/03/2007 | CN1890226A Oxazole derivatives of tetracyclines |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1889977A Vaccine compositions comprising an interleukin 18 and saponin adjuvant system |
| 01/03/2007 | CN1889976A Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 01/03/2007 | CN1889972A Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |